Special Issue Article
Utkalendu Suvendusekhar Samant
The molecular properties of Indian medicinal plants have shown promising results to reduce the inflammation and allergic infections in human beings as per many clinical studies. Recently, the common priorities have been developed to discover traditional therapeutics having significant and pure molecular activities to be useful against the anti-inflammatory and anti-allergic agents to reduce the percentage of infection. In recent years, secondary plant metabolites (phytochemicals), previously with unknown pharmacological activities, have been extensively investigated as a source of medicinal agents. Studies have shown that many of the antioxidant compounds present in Pteridophytes possess anti-inflammatory, antiatherosclerotic, antitumor, antimutagenic, anticarcinogenic, antibacterial, and antiviral activities. The ingestion of natural antioxidants has been associated with reduced risks of cancer, cardiovascular disease, diabetes, and other diseases associated with ageing, allergic and inflammation. From this experiment it has been showed that these plants have phytochemical compounds which help to cure diseases. The results seem to suggest that Pteris and Dryopteris can be a source of powerful anti- inflammatory activity with potential impact on public health, particularly on hypertensive patients.